Form 4 for NVAX NOVAVAX INC
Accepted 2023-06-21 00:00:00 ET · period of report 2023-06-16 · accession 0001209191-23-038804 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-21 | 2023-06-16 | NVAX | Dubovsky Filip | Pres, R, D | F - Tax | $8.04 | -2,007 | 45.1K | -4% | -$16.1K |
| D | 2023-06-21 | 2023-06-16 | NVAX | Dubovsky Filip | Pres, R, D | M - OptEx | $8.04 | +4,155 | 47.1K | +10% | +$33.4K |
| D | 2023-06-21 | 2023-06-16 | NVAX | Dubovsky Filip | Pres, R, D | M - OptEx | $0.00 | -4,155 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-16 | F | D | 2,007 | $8.04 | 45,058 | D | — | — | |
| 2 | Common | Common Stock | 2023-06-16 | M | A | 4,155 | $8.04 | 47,065 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2023-06-16 | M | D | 4,155 | $0.00 | 0 | D | — · — to — | 4,155 Common Stock | (F2) Each RSU represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. (F3) The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the June 16, 2020 grant date, in each case subject to continued employment with the Company through such vesting date. |